Internal Medicine, Geriatric Medicine · Montclair, NJ
NPI
1992862585
Since 2007
Specialty
Internal Medicine, Geriatric Medicine
Code 207RG0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
48 N Fullerton Ave
Montclair, NJ, 07042
Phone (973) 744-7337
Groups this clinician bills Medicare through
Medicare paid, 2024
$422K
4,267 services
Medicare patients, 2024
325
Average age 80
Drug cost, 2024
$1.3M
12,112 prescriptions
Company payments, 2025
$120
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rowen G Diano was code 99309 (snf e&m), 2,258 times for 165 patients. In total Rowen G Diano billed 4,267 services in 34 codes, and Medicare paid $422K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 2,258 | 165 | $94.61 | $214K |
| 99233 Hospital E&M - Subsequent | Facility | 570 | 62 | $105.40 | $60K |
| 99214 Office E&M - Established | Office | 265 | 105 | $107.03 | $28K |
| 99306 SNF E&M | Facility | 146 | 106 | $162.99 | $24K |
| 99308 SNF E&M | Facility | 143 | 42 | $66.56 | $9,519 |
| 36415 Venipuncture Blood Collection | Office | 140 | 82 | $8.65 | $1,211 |
| 99350 Home E&M - New and Established | Office | 117 | 39 | $139.49 | $16K |
| 99310 SNF E&M | Facility | 113 | 62 | $133.12 | $15K |
| 99239 Hospital Discharge Management | Facility | 112 | 62 | $102.38 | $11K |
| 99223 Hospital E&M - Initial | Facility | 68 | 47 | $153.63 | $10K |
| 99215 Office E&M - Established | Office | 66 | 44 | $148.57 | $9,805 |
| 81002 Clinical Chemistry | Office | 50 | 25 | $3.41 | $171 |
| 99213 Office E&M - Established | Office | 45 | 20 | $78.04 | $3,512 |
| 99316 SNF E&M | Facility | 39 | 35 | $117.16 | $4,569 |
| 99205 Office E&M - New | Office | 22 | 22 | $160.49 | $3,531 |
By year: 2022 $394K for 4,177 services; 2023 $717K for 4,681 services; 2024 $422K for 4,267 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 140 | 82 | $8.65 | $1,211 |
| 81002 Clinical Chemistry | 50 | 25 | $3.41 | $171 |
Medicare prescription drug claims, 2024
In 2024, the drug Rowen G Diano prescribed most often to Medicare patients was Atorvastatin Calcium, with 691 prescriptions and refills. In total Rowen G Diano wrote 12,112 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 691 | 1,128 | 146 | $11K |
| Amlodipine Besylate Generic | 484 | 934 | 123 | $3,293 |
| Furosemide Generic | 412 | 557 | 75 | $2,631 |
| Levothyroxine Sodium Generic | 364 | 531 | 64 | $4,887 |
| Eliquis Apixaban | 338 | 360 | 50 | $158K |
| Pantoprazole Sodium Generic | 286 | 401 | 63 | $5,651 |
| Losartan Potassium Generic | 275 | 442 | 66 | $3,672 |
| Oxycodone Hcl Generic | 268 | 268 | 25 | $7,526 |
| Trazodone Hcl Generic | 253 | 366 | 58 | $2,180 |
| Metoprolol Tartrate Generic | 241 | 331 | 53 | $2,042 |
| Alprazolam Generic | 224 | 233 | 45 | $2,137 |
| Escitalopram Oxalate Generic | 207 | 302 | 39 | $2,746 |
| Metoprolol Succinate Generic | 199 | 332 | 50 | $3,504 |
| Sertraline Hcl Generic | 196 | 228 | 25 | $2,426 |
| Divalproex Sodium Generic | 194 | 202 | 26 | $11K |
Brand drugs: 1,902 claims; generic drugs: 10,126 claims; opioid claims: 797.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rowen G Diano $120 ($120 in general payments such as food, travel and fees) from 1 company. The largest payer was Otsuka America Pharmaceutical, Inc. with $120.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.